Sex, gender, and health biotechnology: points to consider
- PMID: 19622163
- PMCID: PMC2726121
- DOI: 10.1186/1472-698X-9-15
Sex, gender, and health biotechnology: points to consider
Abstract
Background: Reproductive technologies have been extensively debated in the literature. As well, feminist economists, environmentalists, and agriculturalists have generated substantial debate and literature on gender. However, the implications for women of health biotechnologies have received relatively less attention. Surprisingly, while gender based frameworks have been proposed in the context of public health policy, practice, health research, and epidemiological research, we could identify no systematic framework for gender analysis of health biotechnology in the developing world.
Discussion: We propose sex and gender considerations at five critical stages of health biotechnology research and development: priority setting; technology design; clinical trials; commercialization, and health services delivery.
Summary: Applying a systematic sex and gender framework to five key process stages of health biotechnology research and development could be a first step towards unlocking the opportunities of this promising science for women in the developing world.
Similar articles
-
How can developing countries harness biotechnology to improve health?BMC Public Health. 2007 Dec 3;7:346. doi: 10.1186/1471-2458-7-346. BMC Public Health. 2007. PMID: 18053180 Free PMC article.
-
Public health context of women's mental health research.Psychiatr Clin North Am. 2003 Sep;26(3):781-99. doi: 10.1016/s0193-953x(03)00039-x. Psychiatr Clin North Am. 2003. PMID: 14563109 Review.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
A research roadmap for complementary and alternative medicine - what we need to know by 2020.Forsch Komplementmed. 2014;21(2):e1-16. doi: 10.1159/000360744. Epub 2014 Mar 24. Forsch Komplementmed. 2014. PMID: 24851850
-
Canadian Contraception Consensus (Part 1 of 4).J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. doi: 10.1016/s1701-2163(16)30033-0. J Obstet Gynaecol Can. 2015. PMID: 26606712 English, French.
References
-
- Gender and Sex-Based Analysis in Health Research: A Guide for CIHR Researchers and Reviewers. http://www.cihr-irsc.gc.ca/e/32019.html
-
- Baldaszti E, Boltzmann L. In: Documentation of the Gender Based Analysis (GBA) in Publich Health Research, Policy and Practice International Workshop: 7–8 June 2001; Berlin. Maschewsky-Schneider U, Kolip P, Sonntag U, editor. Hannover: Landesvereinigung für Gesundheit Niedersachsen; 2001. Gender Based Analysis in the Implementation Process; pp. 57–62.
-
- World Health Organization. Gender Analysis in Health: A Review of Selected Tools. Geneva. 1997.
-
- World Health Organization. Gender and Health: Technical Paper. Geneva. 1998.
LinkOut - more resources
Full Text Sources
Research Materials